Guardant Health (GH) Price to Sales (2018 - 2026)

Guardant Health has disclosed Price to Sales across 9 years of filings, most recently posting 59.84 for Q2 2026.

• In Q2 2026, Price to Sales rose 114.4% year-over-year to 59.84; the TTM figure through Jun 2026 stood at 16.94 (up 116.79% YoY), while the FY2025 annual figure was 13.59, up 165.08% from the prior year.
• Price to Sales came in at 59.84 for Q2 2026 at Guardant Health, up from 40.27 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 70.24 in Q1 2022 to a low of 14.76 in Q3 2024.
• Average Price to Sales over 5 years is 31.74, with a median of 26.9 recorded in 2025.
• Year-over-year, Price to Sales slumped 76.64% in 2022 and jumped 152.74% in 2025.
• Over 5 years, Price to Sales stood at 22.0 in 2022, then decreased by 3.54% to 21.22 in 2023, then dropped by 11.54% to 18.77 in 2024, then soared by 152.74% to 47.44 in 2025, then rose by 26.15% to 59.84 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 59.84 in Q2 2026, 40.27 in Q1 2026, and 47.44 in Q4 2025.